Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion
Clinical trial NCT03223714 · COMPLETED
Trial details
- NCT number
- NCT03223714
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-24
- Primary completion
- 2020-04-13
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.